Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01021007 · ClinicalTrials.gov registry record · Phase 3
Clinical Research Study Efficacy of a Prototype Oral Rinse
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 67
- Enrollment target
NCT01021007: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT01021007 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 67 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01021007, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 67 participants
- Enrollment target
Study Summary
Evaluate the efficacy of an oral rinse on dental plaque and gingival inflammation
Primary Outcome
1 = Mild inflammation-slight change in color and little change in texture 2 = Moderate inflammation-moderate glazing, redness, edema and hypertrophy. Tendency to bleed upon probing. 3 = Severe inflammation-marked redness and hypertrophy. Tendency to spontaneous bleeding
Interventions
- OTHER water
- DRUG Iodine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2007-10 |
| Est. Completion | 2007-11 |
| Phase | Phase 3 |
What the finished NCT01021007 record still lists
NCT01021007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 2 interventions - of which water is the first listed.
NCT01021007 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01021007 about?
NCT01021007 is a clinical study titled "Clinical Research Study Efficacy of a Prototype Oral Rinse". Evaluate the efficacy of an oral rinse on dental plaque and gingival inflammation
What is the current status of trial NCT01021007?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 67 participants. The study started on 2007-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT01021007?
The interventions under investigation include: water (OTHER), Iodine (DRUG).
Who is sponsoring clinical trial NCT01021007?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01021007's enrollment target sits among peer trials
67 1796th of 2000 higher than 204 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia